MED18_HUMAN - dbPTM
MED18_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MED18_HUMAN
UniProt AC Q9BUE0
Protein Name Mediator of RNA polymerase II transcription subunit 18
Gene Name MED18
Organism Homo sapiens (Human).
Sequence Length 208
Subcellular Localization Nucleus .
Protein Description Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors..
Protein Sequence MEAPPVTMMPVTGGTINMMEYLLQGSVLDHSLESLIHRLRGLCDNMEPETFLDHEMVFLLKGQQASPFVLRARRSMDRAGAPWHLRYLGQPEMGDKNRHALVRNCVDIATSENLTDFLMEMGFRMDHEFVAKGHLFRKGIMKIMVYKIFRILVPGNTDSTEALSLSYLVELSVVAPAGQDMVSDDMKNFAEQLKPLVHLEKIDPKRLM
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
66PhosphorylationLLKGQQASPFVLRAR
HHHCCCCCHHHHHHH
17.9630266825
78MethylationRARRSMDRAGAPWHL
HHHCCHHCCCCCCEE
26.69115483127
93SulfoxidationRYLGQPEMGDKNRHA
EECCCCCCCCCCHHH
12.2321406390
96UbiquitinationGQPEMGDKNRHALVR
CCCCCCCCCHHHHHH
50.5933845483
103UbiquitinationKNRHALVRNCVDIAT
CCHHHHHHHHHHHHC
31.5121906983
125SulfoxidationLMEMGFRMDHEFVAK
HHHCCCCCCHHHHHC
6.0330846556
194UbiquitinationKNFAEQLKPLVHLEK
HHHHHHHHHHHHHHH
35.6829967540
201UbiquitinationKPLVHLEKIDPKRLM
HHHHHHHHCCHHHCC
59.7929967540

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of MED18_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MED18_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference
66Phosphorylation74 (8)RCrs139242087
  • Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)
28090653
78Methylation74 (4)RCrs139242087
  • Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)
28090653

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MED20_HUMANMED20physical
12584197
MED13_HUMANMED13physical
15989967
MED12_HUMANMED12physical
15989967
MED1_HUMANMED1physical
15989967
MED17_HUMANMED17physical
15989967
MED20_HUMANMED20physical
15989967
MED21_HUMANMED21physical
15989967
MED12_HUMANMED12physical
20133760
MED13_HUMANMED13physical
20133760
CCNC_HUMANCCNCphysical
20133760
MED16_HUMANMED16physical
20133760
MED17_HUMANMED17physical
20133760
MED1_HUMANMED1physical
20133760
MED28_HUMANMED28physical
20133760
MED24_HUMANMED24physical
20133760
MED22_HUMANMED22physical
20133760
MED23_HUMANMED23physical
20133760
MED4_HUMANMED4physical
20133760
MED29_HUMANMED29physical
20133760
MED8_HUMANMED8physical
20133760
MED31_HUMANMED31physical
20133760
MED15_HUMANMED15physical
20133760
MED6_HUMANMED6physical
20133760
MED14_HUMANMED14physical
20133760
MED30_HUMANMED30physical
20133760
MED26_HUMANMED26physical
20133760
MED10_HUMANMED10physical
20133760
MED27_HUMANMED27physical
20133760
MED20_HUMANMED20physical
20133760
MED21_HUMANMED21physical
20133760
MED4_HUMANMED4physical
22939629
MED1_HUMANMED1physical
22939629
MED24_HUMANMED24physical
22939629
MED8_HUMANMED8physical
22939629
MED21_HUMANMED21physical
22939629
PI42B_HUMANPIP4K2Bphysical
22939629
TRI39_HUMANTRIM39physical
25416956
HOMEZ_HUMANHOMEZphysical
25416956
MED1_HUMANMED1physical
26344197
MED11_HUMANMED11physical
26344197
MED12_HUMANMED12physical
26344197
MED14_HUMANMED14physical
26344197
MED15_HUMANMED15physical
26344197
MED16_HUMANMED16physical
26344197
MED17_HUMANMED17physical
26344197
MED19_HUMANMED19physical
26344197
MED23_HUMANMED23physical
26344197
MED24_HUMANMED24physical
26344197
MED27_HUMANMED27physical
26344197
MED4_HUMANMED4physical
26344197
MED8_HUMANMED8physical
26344197
TRI39_HUMANTRIM39physical
21516116
MED19_HUMANMED19physical
28514442
MED1_HUMANMED1physical
28514442
MED7_HUMANMED7physical
28514442
CCNC_HUMANCCNCphysical
28514442
MED8_HUMANMED8physical
28514442
MED26_HUMANMED26physical
28514442
MED27_HUMANMED27physical
28514442
MED28_HUMANMED28physical
28514442
MED20_HUMANMED20physical
28514442
MED13_HUMANMED13physical
28514442
MED17_HUMANMED17physical
28514442
MD13L_HUMANMED13Lphysical
28514442
MED6_HUMANMED6physical
28514442
MED22_HUMANMED22physical
28514442
MD12L_HUMANMED12Lphysical
28514442
MED9_HUMANMED9physical
28514442
MED24_HUMANMED24physical
28514442
MED14_HUMANMED14physical
28514442
MED10_HUMANMED10physical
28514442
MED31_HUMANMED31physical
28514442
MED4_HUMANMED4physical
28514442
MED11_HUMANMED11physical
28514442
MED30_HUMANMED30physical
28514442
MED16_HUMANMED16physical
28514442
MED23_HUMANMED23physical
28514442
MED25_HUMANMED25physical
28514442
MED12_HUMANMED12physical
28514442
MED29_HUMANMED29physical
28514442
MED15_HUMANMED15physical
28514442
CDK19_HUMANCDK19physical
28514442
CDK8_HUMANCDK8physical
28514442
MTMR3_HUMANMTMR3physical
28514442
G6PD_HUMANG6PDphysical
28514442
MTMR4_HUMANMTMR4physical
28514442
RPAP2_HUMANRPAP2physical
28514442
GPN3_HUMANGPN3physical
28514442
RPB1_HUMANPOLR2Aphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MED18_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66, AND MASSSPECTROMETRY.

TOP